Clinical Trial Update: A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma

View source ↗

Summary

This clinical trial update notes that the study evaluating the urinary biomarker Kidney Injury Molecule-1 for detecting renal cell carcinoma has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Jason Hafron | Conditions: Renal Cell Carcinoma | Status: TERMINATED